Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucagon-like peptide-1 (GLP-1) receptor agonist. In the SURMOUNT-1 clinical trial, the average weight loss with tirzepatide after 72 weeks was 15% for the 5mg dose, 19.5% for the 10mg dose, and 20.9% for the 15mg dose.
This product will require reconstitution – we sell the items needed for reconstitution here. Concentration Each vial of Semathin Tirzepatide contains 4mg of active Tirzepatide. Half-Life Tirzepatide has an approximate half-life of 165 hours, making once-weekly dosing both optimal and convenient. Possible Side Effects Many users report mild side effects in their first few days of using Tirzepatide, namely nausea, light-headedness, and reflux can occur. Users should find these unwanted effects to subside after a few days of use, but be mindful that increasing dosage later may prompt their return. Disclaimer Products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticidal product, food additive, or household chemical – and may not be misbranded as such. All information on this website is available for educational purposes only. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.